Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system by Demetria M. Bolden, Vanessa Richardson, Taufiq Salahuddin, Kamal Henderson, Paul L. Hess, Sridharan Raghavan, David R. Saxon, P. Michael Ho, Stephen W. Waldo, Gregory G. Schwartz

Get full text